Aurigene Pharmaceutical Services commitment towards quality is validated by the various global accreditations of our R&D and manufacturing facilities. This provides our customers with the assurance that their drug compound projects are executed in state-of-the-art cGMP facilities. In addition, our high standards of quality, capabilities and expertise are regularly reviewed in numerous customer audits during the year.
Our state-of-the-art preclinical evaluation safety facility has been audited by FCPSA Netherlands, DGCI and annually audited by National GLP Compliance Monitoring Authority (NGCMA). Our facility has also been audited by the US FDA and the quality systems in this facility are in accordance with NGCMA and US FDA standards.